Catalent Stock Price, News & Analysis (NYSE:CTLT)

$42.81 +0.33 (+0.78 %)
(As of 02/21/2018 04:00 PM ET)
Previous Close$42.81
Today's Range$42.51 - $44.01
52-Week Range$27.48 - $47.87
Volume899,370 shs
Average Volume1.01 million shs
Market Capitalization$5.69 billion
P/E Ratio77.84
Dividend YieldN/A
Beta1.47

About Catalent (NYSE:CTLT)

Catalent logoCatalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels. The Drug Delivery Solutions segment is engaged in the formulation, development and manufacturing of prescription and consumer and animal health products; blow-fill seal unit dose manufacturing; biologic cell line development; analytical and bioanalytical development, and testing services. The Clinical Supply Services segment is engaged in manufacturing, packaging, labeling, storage, distribution and inventory management for clinical trials of drugs and biologics for patient kits; FastChain clinical supply service; clinical e-solutions and informatics, and global comparator sourcing services.

Receive CTLT News and Ratings via Email

Sign-up to receive the latest news and ratings for CTLT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceuticals
Sub-IndustryN/A
SectorHealthcare
SymbolNYSE:CTLT
CUSIPN/A
Phone+1-732-5376200

Debt

Debt-to-Equity Ratio2.66%
Current Ratio2.22%
Quick Ratio1.78%

Price-To-Earnings

Trailing P/E Ratio77.8363636363636
Forward P/E Ratio27.98
P/E Growth2.49

Sales & Book Value

Annual Sales$2.08 billion
Price / Sales2.75
Cash Flow$2.56 per share
Price / Cash16.72
Book Value$7.54 per share
Price / Book5.68

Profitability

Trailing EPS$0.55
Net Income$109.80 million
Net Margins3.03%
Return on Equity23.85%
Return on Assets5.46%

Miscellaneous

Employees10,800
Outstanding Shares133,320,000

Catalent (NYSE:CTLT) Frequently Asked Questions

What is Catalent's stock symbol?

Catalent trades on the New York Stock Exchange (NYSE) under the ticker symbol "CTLT."

How were Catalent's earnings last quarter?

Catalent Inc (NYSE:CTLT) announced its quarterly earnings results on Monday, February, 5th. The company reported $0.41 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.31 by $0.10. The business earned $606.30 million during the quarter, compared to the consensus estimate of $565.05 million. Catalent had a net margin of 3.03% and a return on equity of 23.85%. The business's revenue was up 25.3% compared to the same quarter last year. During the same quarter last year, the firm earned $0.27 EPS. View Catalent's Earnings History.

When will Catalent make its next earnings announcement?

Catalent is scheduled to release their next quarterly earnings announcement on Wednesday, May, 2nd 2018. View Earnings Estimates for Catalent.

Where is Catalent's stock going? Where will Catalent's stock price be in 2018?

11 brokerages have issued 1 year target prices for Catalent's stock. Their forecasts range from $38.00 to $50.00. On average, they expect Catalent's stock price to reach $45.33 in the next twelve months. View Analyst Ratings for Catalent.

Who are some of Catalent's key competitors?

Who are Catalent's key executives?

Catalent's management team includes the folowing people:

  • John R. Chiminski, Chairman of the Board, President, Chief Executive Officer (Age 53)
  • Wetteny Joseph, Chief Financial Officer, Senior Vice President (Age 45)
  • Aristippos Gennadios Ph.D., President - Softgel Technologies (Age 52)
  • Barry B. Littlejohns, President - Drug Delivery Solutions (Age 51)
  • Steven L. Fasman, Senior Vice President, General Counsel and Corporate Secretary (Age 55)
  • William Downie, Senior Vice President - Global Marketing & Sales (Age 50)
  • Lance Miyamoto, Senior Vice President - Global Human Resources (Age 62)
  • Christine Dolan, Senior Vice President - Product Development (Age 49)
  • Scott Gunther, Senior Vice President - Quality & Regulatory Affairs (Age 50)
  • Alessandro Maselli, Senior Vice President - Global Operations (Age 45)

Who owns Catalent stock?

Catalent's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (12.54%), Schroder Investment Management Group (2.78%), Champlain Investment Partners LLC (2.28%), American Century Companies Inc. (1.98%), Earnest Partners LLC (1.87%) and Brown Advisory Inc. (1.52%). Company insiders that own Catalent stock include Blackstone Management Associat, Christine Dolan, Donald E Morel, Jr, John R Chiminski, Matthew M Walsh, Sharon Johnson and Uwe Roehrhoff. View Institutional Ownership Trends for Catalent.

Who sold Catalent stock? Who is selling Catalent stock?

Catalent's stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, BlackRock Inc., Bank of Montreal Can, Renaissance Technologies LLC, Two Sigma Investments LP, Goldman Sachs Group Inc., Schroder Investment Management Group and Metropolitan Life Insurance Co. NY. Company insiders that have sold Catalent company stock in the last year include Christine Dolan, John R Chiminski and Sharon Johnson. View Insider Buying and Selling for Catalent.

Who bought Catalent stock? Who is buying Catalent stock?

Catalent's stock was bought by a variety of institutional investors in the last quarter, including American Century Companies Inc., Redmile Group LLC, Carillon Tower Advisers Inc., Hood River Capital Management LLC, Champlain Investment Partners LLC, Guggenheim Capital LLC, Segall Bryant & Hamill LLC and Fuller & Thaler Asset Management Inc.. Company insiders that have bought Catalent stock in the last two years include Donald E Morel, Jr and Uwe Roehrhoff. View Insider Buying and Selling for Catalent.

How do I buy Catalent stock?

Shares of Catalent can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Catalent's stock price today?

One share of Catalent stock can currently be purchased for approximately $42.81.

How big of a company is Catalent?

Catalent has a market capitalization of $5.69 billion and generates $2.08 billion in revenue each year. The company earns $109.80 million in net income (profit) each year or $0.55 on an earnings per share basis. Catalent employs 10,800 workers across the globe.

How can I contact Catalent?

Catalent's mailing address is 14 Schoolhouse Rd, SOMERSET, NJ 08873-1213, United States. The company can be reached via phone at +1-732-5376200 or via email at [email protected]


MarketBeat Community Rating for Catalent (CTLT)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  196 (Vote Outperform)
Underperform Votes:  212 (Vote Underperform)
Total Votes:  408
MarketBeat's community ratings are surveys of what our community members think about Catalent and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Catalent (NYSE:CTLT) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.672.702.672.63
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $45.33$44.00$41.38$30.83
Price Target Upside: 6.24% upside5.31% upside3.36% upside13.99% downside

Catalent (NYSE:CTLT) Consensus Price Target History

Price Target History for Catalent (NYSE:CTLT)

Catalent (NYSE:CTLT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/6/2018Bank of AmericaBoost Price TargetBuy -> Buy$47.00 -> $49.00MediumView Rating Details
2/6/2018StephensDowngradeOverweight -> Equal WeightHighView Rating Details
2/5/2018Royal Bank of CanadaSet Price TargetBuy$48.00HighView Rating Details
1/24/2018Goldman Sachs GroupInitiated CoverageBuy$50.00HighView Rating Details
1/5/2018First AnalysisInitiated CoverageEqual WeightLowView Rating Details
11/7/2017Piper Jaffray CompaniesBoost Price TargetOverweight$45.00 -> $50.00N/AView Rating Details
10/23/2017Needham & Company LLCReiterated RatingHoldN/AView Rating Details
9/21/2017Morgan StanleyUpgradeEqual Weight -> Overweight$29.00 -> $48.00HighView Rating Details
9/20/2017Wells Fargo & CoBoost Price TargetOutperform$39.00 -> $43.00LowView Rating Details
8/29/2017William BlairReiterated RatingOurperformHighView Rating Details
8/29/2017Jefferies GroupReiterated RatingHold$35.00 -> $38.00HighView Rating Details
8/29/2017JPMorgan Chase & Co.Reiterated RatingBuy$40.00HighView Rating Details
10/20/2016KeyCorpInitiated CoverageOverweight$29.00N/AView Rating Details
(Data available from 2/21/2016 forward)

Earnings

Catalent (NYSE:CTLT) Earnings History and Estimates Chart

Earnings by Quarter for Catalent (NYSE:CTLT)

Catalent (NYSE CTLT) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2018$0.40N/AView Earnings Details
2/5/2018Q2 2018$0.31$0.41$565.05 million$606.30 millionViewN/AView Earnings Details
11/6/2017Q1 2018$0.20$0.21$490.75 million$543.90 millionViewN/AView Earnings Details
8/28/2017Q4 2017$0.57$0.65$547.48 million$616.90 millionViewN/AView Earnings Details
5/4/2017Q3 2017$0.36$0.38$470.95 million$532.60 millionViewListenView Earnings Details
2/6/2017Q217$0.27$0.27$474.07 million$483.70 millionViewListenView Earnings Details
11/7/2016Q117$0.13$0.16$430.26 million$442.20 millionViewListenView Earnings Details
8/29/2016Q416$0.53$0.52$498.06 million$532.20 millionViewListenView Earnings Details
5/4/2016Q316$0.31$0.20$425.92 million$438.00 millionViewN/AView Earnings Details
2/9/2016Q216$0.34$0.36$441.99 million$454.90 millionViewN/AView Earnings Details
11/3/2015Q116$0.21$0.14$407.80 million$423.00 millionViewN/AView Earnings Details
9/2/2015Q415$0.58$0.60$496.91 million$510.10 millionViewN/AView Earnings Details
5/5/2015Q3 2015$0.43$0.46$453.25 million$446.60 millionViewN/AView Earnings Details
2/11/2015Q215$0.33$0.44$451.40 million$455.80 millionViewN/AView Earnings Details
11/13/2014Q314$0.20$0.13$411.20 million$418.30 millionViewN/AView Earnings Details
9/4/2014Q4 2014$1.03$519.60 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Catalent (NYSE:CTLT) Earnings Estimates

2018 EPS Consensus Estimate: $1.20
2019 EPS Consensus Estimate: $1.80
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20181$0.29$0.29$0.29
Q3 20181$0.36$0.36$0.36
Q4 20182$0.55$0.55$0.55
Q1 20191$0.26$0.26$0.26
Q2 20192$0.44$0.48$0.46
Q3 20191$0.42$0.42$0.42
Q4 20191$0.66$0.66$0.66
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Catalent (NYSE:CTLT)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Catalent (NYSE CTLT) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.70%
Institutional Ownership Percentage: 99.82%
Insider Trades by Quarter for Catalent (NYSE:CTLT)
Institutional Ownership by Quarter for Catalent (NYSE:CTLT)

Catalent (NYSE CTLT) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/12/2017John R ChiminskiInsiderSell181,458$39.62$7,189,365.96View SEC Filing  
11/21/2017Uwe RoehrhoffDirectorBuy7,500$39.22$294,150.00View SEC Filing  
8/29/2017Christine DolanSVPSell1,594$38.75$61,767.50View SEC Filing  
8/1/2017Christine DolanSVPSell745$34.85$25,963.25View SEC Filing  
4/25/2017Sharon JohnsonInsiderSell9,160$29.00$265,640.00View SEC Filing  
3/20/2017John R. ChiminskiInsiderSell73,819$28.62$2,112,699.78View SEC Filing  
2/15/2017Donald E. Morel, Jr.DirectorBuy10,000$29.27$292,700.00View SEC Filing  
9/9/2016Blackstone Management AssociatMajor ShareholderSell17,100,705$23.58$403,234,623.90View SEC Filing  
6/9/2016Blackstone Management AssociatMajor ShareholderSell8,785,539$24.51$215,333,560.89View SEC Filing  
5/27/2016Matthew M WalshInsiderSell21,197$28.85$611,533.45105,688View SEC Filing  
8/19/2015John R ChiminskiInsiderSell38,505$33.81$1,301,854.05View SEC Filing  
8/17/2015John R ChiminskiInsiderSell35,550$33.80$1,201,590.00View SEC Filing  
7/20/2015John R ChiminskiInsiderSell33,081$29.40$972,581.40View SEC Filing  
7/6/2015John R ChiminskiInsiderSell33,828$29.34$992,513.52View SEC Filing  
6/11/2015Blackstone Management AssociatMajor ShareholderSell1,844,963$28.13$51,898,809.19View SEC Filing  
6/8/2015Blackstone Management AssociatMajor ShareholderSell12,299,753$28.13$345,992,051.89View SEC Filing  
4/1/2015Scott HoultonInsiderSell16,253$30.61$497,504.33View SEC Filing  
3/27/2015Stephen LeonardInsiderSell31,005$30.13$934,180.65View SEC Filing  
2/17/2015Scott HoultonInsiderSell14,538$27.50$399,795.00View SEC Filing  
2/13/2015Scott HoultonInsiderSell1,400$28.28$39,592.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Catalent (NYSE CTLT) News Headlines

Source:
DateHeadline
Catalent (CTLT) Downgraded by Zacks Investment ResearchCatalent (CTLT) Downgraded by Zacks Investment Research
www.americanbankingnews.com - February 21 at 10:00 PM
Catalent (CTLT) Upgraded at Zacks Investment ResearchCatalent (CTLT) Upgraded at Zacks Investment Research
www.americanbankingnews.com - February 20 at 8:58 PM
Comparing Catalent (CTLT) & BioLife Solutions (BLFS)Comparing Catalent (CTLT) & BioLife Solutions (BLFS)
www.americanbankingnews.com - February 18 at 3:16 AM
$609.36 Million in Sales Expected for Catalent Inc (CTLT) This Quarter$609.36 Million in Sales Expected for Catalent Inc (CTLT) This Quarter
www.americanbankingnews.com - February 17 at 11:44 AM
Catalent, Inc. to Present at Two Upcoming Investor ConferencesCatalent, Inc. to Present at Two Upcoming Investor Conferences
finance.yahoo.com - February 15 at 4:49 PM
Zacks: Brokerages Expect Catalent Inc (CTLT) to Post $0.40 Earnings Per ShareZacks: Brokerages Expect Catalent Inc (CTLT) to Post $0.40 Earnings Per Share
www.americanbankingnews.com - February 15 at 3:18 AM
Catalent Inc (CTLT) Receives Average Rating of "Buy" from AnalystsCatalent Inc (CTLT) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - February 9 at 12:18 PM
Catalent Inc (CTLT) to Post Q3 2018 Earnings of $0.36 Per Share, William Blair ForecastsCatalent Inc (CTLT) to Post Q3 2018 Earnings of $0.36 Per Share, William Blair Forecasts
www.americanbankingnews.com - February 9 at 11:36 AM
Catalent Inc (CTLT) to Post Q2 2019 Earnings of $0.48 Per Share, First Analysis ForecastsCatalent Inc (CTLT) to Post Q2 2019 Earnings of $0.48 Per Share, First Analysis Forecasts
www.americanbankingnews.com - February 8 at 4:38 PM
KeyCorp Weighs in on Catalent Incs Q4 2018 Earnings (CTLT)KeyCorp Weighs in on Catalent Inc's Q4 2018 Earnings (CTLT)
www.americanbankingnews.com - February 8 at 3:34 PM
FY2018 EPS Estimates for Catalent Inc Increased by William Blair (CTLT)FY2018 EPS Estimates for Catalent Inc Increased by William Blair (CTLT)
www.americanbankingnews.com - February 8 at 1:44 PM
FY2018 EPS Estimates for Catalent Inc (CTLT) Lifted by AnalystFY2018 EPS Estimates for Catalent Inc (CTLT) Lifted by Analyst
www.americanbankingnews.com - February 8 at 1:44 PM
Catalent (CTLT) Rating Lowered to Equal Weight at StephensCatalent (CTLT) Rating Lowered to Equal Weight at Stephens
www.americanbankingnews.com - February 7 at 12:40 AM
Catalent (CTLT) Given New $49.00 Price Target at Bank of AmericaCatalent (CTLT) Given New $49.00 Price Target at Bank of America
www.americanbankingnews.com - February 6 at 12:58 PM
Catalent (CTLT) Receives Buy Rating from Royal Bank of CanadaCatalent (CTLT) Receives Buy Rating from Royal Bank of Canada
www.americanbankingnews.com - February 5 at 8:12 PM
Catalent (CTLT) Announces  Earnings ResultsCatalent (CTLT) Announces Earnings Results
www.americanbankingnews.com - February 5 at 11:16 AM
Catalent, Inc. Reports Second Quarter Fiscal 2018 ResultsCatalent, Inc. Reports Second Quarter Fiscal 2018 Results
www.bizjournals.com - February 5 at 9:21 AM
Catalent reports 2Q lossCatalent reports 2Q loss
www.cnbc.com - February 5 at 9:21 AM
Should You Sell Catalent (CTLT) Before Earnings?Should You Sell Catalent (CTLT) Before Earnings?
finance.yahoo.com - February 1 at 9:28 AM
Analyzing Catalent (CTLT) and AMAG Pharmaceuticals (AMAG)Analyzing Catalent (CTLT) and AMAG Pharmaceuticals (AMAG)
www.americanbankingnews.com - January 31 at 3:14 PM
 Analysts Expect Catalent Inc (CTLT) Will Post Quarterly Sales of $568.29 Million Analysts Expect Catalent Inc (CTLT) Will Post Quarterly Sales of $568.29 Million
www.americanbankingnews.com - January 31 at 9:45 AM
Catalent (CTLT) Scheduled to Post Quarterly Earnings on MondayCatalent (CTLT) Scheduled to Post Quarterly Earnings on Monday
www.americanbankingnews.com - January 29 at 3:20 AM
Catalent (CTLT) Research Coverage Started at Goldman Sachs GroupCatalent (CTLT) Research Coverage Started at Goldman Sachs Group
www.americanbankingnews.com - January 28 at 5:10 PM
Catalent (CTLT) Rating Lowered to Hold at Zacks Investment ResearchCatalent (CTLT) Rating Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - January 18 at 10:54 PM
Zacks Investment Research Upgrades Catalent (CTLT) to "Buy"Zacks Investment Research Upgrades Catalent (CTLT) to "Buy"
www.americanbankingnews.com - January 17 at 10:40 PM
Catalent, Inc. Announces Second Quarter Fiscal Year 2018 Earnings Conference WebcastCatalent, Inc. Announces Second Quarter Fiscal Year 2018 Earnings Conference Webcast
finance.yahoo.com - January 16 at 5:03 PM
Catalent Inc (CTLT) Given Consensus Recommendation of "Buy" by BrokeragesCatalent Inc (CTLT) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - January 15 at 11:42 AM
$567.62 Million in Sales Expected for Catalent Inc (CTLT) This Quarter$567.62 Million in Sales Expected for Catalent Inc (CTLT) This Quarter
www.americanbankingnews.com - January 14 at 12:00 PM
William Blair Analysts Boost Earnings Estimates for Catalent Inc (CTLT)William Blair Analysts Boost Earnings Estimates for Catalent Inc (CTLT)
www.americanbankingnews.com - January 12 at 3:40 PM
Catalent Inc (CTLT) Expected to Post Earnings of $0.34 Per ShareCatalent Inc (CTLT) Expected to Post Earnings of $0.34 Per Share
www.americanbankingnews.com - January 12 at 5:14 AM
Q2 2018 EPS Estimates for Catalent Inc (CTLT) Cut by William BlairQ2 2018 EPS Estimates for Catalent Inc (CTLT) Cut by William Blair
www.americanbankingnews.com - January 11 at 12:40 PM
Catalent (CTLT) & Valeant Pharmaceuticals Intl (VRX) Critical AnalysisCatalent (CTLT) & Valeant Pharmaceuticals Intl (VRX) Critical Analysis
www.americanbankingnews.com - January 11 at 5:36 AM
Zacks Investment Research Upgrades Catalent (CTLT) to HoldZacks Investment Research Upgrades Catalent (CTLT) to Hold
www.americanbankingnews.com - January 9 at 8:58 PM
Catalent (CTLT) Now Covered by First AnalysisCatalent (CTLT) Now Covered by First Analysis
www.americanbankingnews.com - January 5 at 4:52 PM
Analyzing Catalent (CTLT) & Neuralstem (CUR)Analyzing Catalent (CTLT) & Neuralstem (CUR)
www.americanbankingnews.com - January 4 at 1:32 PM
New Strong Sell Stocks for December 29th - NasdaqNew Strong Sell Stocks for December 29th - Nasdaq
www.nasdaq.com - December 29 at 10:19 AM
New Strong Sell Stocks for December 29thNew Strong Sell Stocks for December 29th
finance.yahoo.com - December 29 at 10:19 AM
$567.30 Million in Sales Expected for Catalent Inc (CTLT) This Quarter$567.30 Million in Sales Expected for Catalent Inc (CTLT) This Quarter
www.americanbankingnews.com - December 28 at 2:26 PM
ETFs with exposure to Catalent, Inc. : December 27, 2017ETFs with exposure to Catalent, Inc. : December 27, 2017
finance.yahoo.com - December 28 at 6:10 AM
Comparing Catalent (CTLT) & Its RivalsComparing Catalent (CTLT) & Its Rivals
www.americanbankingnews.com - December 28 at 1:10 AM
$0.34 EPS Expected for Catalent Inc (CTLT) This Quarter$0.34 EPS Expected for Catalent Inc (CTLT) This Quarter
www.americanbankingnews.com - December 26 at 6:18 PM
Reviewing Catalent (CTLT) and Its RivalsReviewing Catalent (CTLT) and Its Rivals
www.americanbankingnews.com - December 26 at 9:24 AM
Catalent, Inc. :CTLT-US: Earnings Analysis: Q1, 2018 By the Numbers : December 26, 2017Catalent, Inc. :CTLT-US: Earnings Analysis: Q1, 2018 By the Numbers : December 26, 2017
finance.yahoo.com - December 26 at 9:15 AM
Comparing Catalent (CTLT) and Its CompetitorsComparing Catalent (CTLT) and Its Competitors
www.americanbankingnews.com - December 25 at 7:29 PM
Reviewing Catalent (CTLT) & Its CompetitorsReviewing Catalent (CTLT) & Its Competitors
www.americanbankingnews.com - December 23 at 9:28 AM
Catalent (CTLT) and Its Peers Head to Head AnalysisCatalent (CTLT) and Its Peers Head to Head Analysis
www.americanbankingnews.com - December 22 at 1:24 PM
Catalent Inc (CTLT) Given Average Recommendation of "Hold" by BrokeragesCatalent Inc (CTLT) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - December 21 at 11:52 AM
Catalent (CTLT) vs. Its Peers Critical ReviewCatalent (CTLT) vs. Its Peers Critical Review
www.americanbankingnews.com - December 21 at 5:16 AM
Zacks Investment Research Lowers Catalent (CTLT) to SellZacks Investment Research Lowers Catalent (CTLT) to Sell
www.americanbankingnews.com - December 20 at 6:34 PM
Catalent (CTLT) versus Its Competitors Head to Head SurveyCatalent (CTLT) versus Its Competitors Head to Head Survey
www.americanbankingnews.com - December 20 at 9:32 AM

SEC Filings

Catalent (NYSE:CTLT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Catalent (NYSE:CTLT) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Catalent (NYSE CTLT) Stock Chart for Wednesday, February, 21, 2018

Loading chart…

This page was last updated on 2/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.